Expert consensus on clinical practice for the diagnosis and treatment of hepatic vascular diseases （2026 edition）
10.12449/JCH260107
- VernacularTitle:肝脏血管性疾病诊治临床实践专家共识（2026年版）
- Author:
- Publication Type:Journal Article
- Keywords:
Hepatic Vascular Diseases;
Diagnosis;
Therapeutics;
Hypertension， Portal;
Practice Guideline
- From:
Journal of Clinical Hepatology
2026;42(1):47-65
- CountryChina
- Language:Chinese
-
Abstract:
Hepatic vascular diseases （such as portal vein thrombosis， porto-sinusoidal vascular disease， hereditary hemorrhagic telangiectasia， arterioportal fistula， and sinusoidal obstruction syndrome， Budd-Chiari syndrome） are characterized by diverse clinical manifestations， difficulties in diagnosis， and various treatment regimens， which brings huge challenges to clinical diagnosis and treatment， and at present， there are still no guidelines or consensus statements on the diagnosis and treatment of hepatic vascular diseases in China. To standardize and improve the diagnosis and treatment of hepatic vascular diseases in China， Committee on Liver Diseases （Integrated Traditional Chinese and Western Medicine） of China Research Hospital Association， Committee on Interventional Medicine of China Research Hospital Association， and Branch for Multidisciplinary Diagnosis and Treatment of Portal Hypertension of Beijing Medical Doctor Association organized the experts in related fields to develop expert consensus on clinical practice for the diagnosis and treatment of hepatic vascular diseases （2025 edition） based on the latest evidence-based medical research and the clinical practice in China， with a focus on the diagnosis and treatment of hepatic vascular diseases.
